BONE BIOLOGICS CORPORATION Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.55 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $1.55, a 59.79% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.97, a 73.92% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.72, a 1450.00% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.24, a 93.46% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $5.41, a 60.80% decline from fiscal 2024.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $13.80, a 153.68% increase from fiscal 2023.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $5.44, a 99.13% decline from fiscal 2022.
- BONE BIOLOGICS CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $624.00, a 14616.98% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.55 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $1.55 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $5.41 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $5.41 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $5.41 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | $0.97 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | $13.80 10-K · filed 2026-03-02 | $2.30 10-K · filed 2025-02-26 | |||
| 2024-09-30 | $2.39 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $3.72 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | $3.72 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $5.44 10-K · filed 2025-02-26 | ||||
| 2023-09-30 | $0.68 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $7.20 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $0.24 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $624.00 10-K · filed 2024-02-21 | $2.60 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $2.60 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $3.67 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $3.67 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | $4.24 10-K · filed 2023-03-30 | ||||
| 2019-12-31 | $19.70 10-K · filed 2021-04-15 | $0.94 10-K · filed 2020-03-30 | |||
| 2019-09-30 | $0.94 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | $0.94 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $0.94 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | $19.70 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $19.70 10-Q · filed 2018-11-16 | ||||
| 2018-06-30 | $19.70 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | $1.97 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | $20.50 10-K · filed 2019-03-29 | $2.05 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $2.05 10-Q · filed 2017-11-14 | ||||
| 2017-06-30 | $2.05 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | $2.05 10-Q · filed 2017-05-12 | ||||
| 2016-12-31 | $1.66 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $1.66 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $1.66 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | $1.59 10-Q · filed 2016-05-13 | ||||
| 2015-12-31 | $1.59 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $1.58 10-Q · filed 2015-11-16 | ||||
| 2014-12-31 | $1.59 10-K · filed 2016-03-28 | $1.00 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |